SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ADTX

Aditxt, Inc. (ADTX)

United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.00+$0.00 (+33.33%)
 
Market cap
$399K
Insider Score
Website
Market Cap$399.19K+33.3%
Revenue (ttm)$14.34K
Net Income-$53.34M
EPS$25450142.00
Shares Out997.98M
PE Ratio0.00
Forward PE-0.00
Dividendn/a
Ex-Dividend Daten/a
Volume9,762,594
Open$0.00
Previous Close$0.00
Day's Range$0.00 - $0.00
52-Week Range$0.00 - $896.40
Betan/a
Analystsnone
Price Targetn/a
Earnings Daten/a
No price history available.

About ADTX

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes. In addition, the company provides Pearsanta that develops molecular tests based on the mitochondrial DNA (mtDNA) to develop tests for early detection of cancer; Mitomic targets mutations in mitochondrial DNA (mtDNA) to detect disease; Mitomic prostate test a blood-based assay that quantifies the level of the 3.4kb mtDNA deletion; and Mitomic endometriosis test, a blood-based assay that quantifies the level of one or more mtDNA deletions. Further, it offers Adivir for commercial development of products to address significant unmet needs in infectious disease and population health; and Adifem address critical unmet needs in women health. The company has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Address
2569 Wyandotte Street, Mountain View, CA, 94043, United States
Market Cap
0 million
Employees
26
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.00K
Bought
$0.05

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only

Not enough price history.

1 Day
+33.33%
5 Days
+0.00%
1 Month
+0.00%
6 Months
+0.00%
1 Year
+33.33%

$ADTX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ADTX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ADTX's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ADTX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ADTX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ADTX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from ADTX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
12
Sells
14
Buy Value
$0.05
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.